Melissa Calton, Ph.D.

Melissa Calton, Ph.D. has a diverse and extensive work experience. Melissa currently holds the position of Senior Director, Translational Medicine- Project Team Leader at 4D Molecular Therapeutics since July 2022. Prior to this role, they served as the Director, Translational Medicine/Preclinical Program Leader from December 2020 to July 2022, and as the Associate Director, Translational Medicine, Program Leader from October 2019 to December 2020, both at 4D Molecular Therapeutics.

Before joining 4D Molecular Therapeutics, Melissa worked at Verseon from September 2016 to October 2019. Melissa held the position of Senior Scientist, Program Manager of Ophthalmology from August 2018 to October 2019, and prior to that, they worked as a Scientist from September 2016 to August 2018.

Melissa also has experience working at renowned academic institutions. Melissa worked at Stanford University as a Postdoctoral Scholar from January 2011 to August 2016. Prior to that, they pursued their Ph.D. at the University of California, San Francisco, where they served as a PhD Candidate from August 2005 to December 2010.

Overall, Melissa Calton, Ph.D. has shown career progression and expertise in the field of translational medicine, preclinical programs, and ophthalmology.

Dr. Melissa Calton obtained their Bachelor's degree in Biology, Chemistry, and Spanish from Missouri State University, where they studied from 1998 to 2002. Melissa then pursued their Ph.D. in Pharmaceutical Sciences & Pharmacogenomics at the University of California, San Francisco, completing their doctoral studies from 2005 to 2010. Following this, they engaged in a postdoctoral position at Stanford University, specializing in Genetics, which they completed from 2011 to 2016.